Physician

Adnan Muhammad, M.D.

According to 2025 Medicare claims, Adnan Muhammad, M.D. (NPI: 1942242938) practices hematology in the Tampa, FL market, with the plurality of this provider's patient population coming from Hillsborough, FL. This provider's primary affiliated billing organization is FLORIDA HOSPITAL PHYSICIAN GROUP INC (NPI: 1174955256; TIN: 462021581) and primary practice location at 33613-4613.

Muhammad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 220 traditional Medicare patients, billed 496 HCPCS/CPT codes, and received $46,106 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 513 prescription claims across 139 beneficiaries totaling $460,766 in drug costs, led by Xifaxan (Rifaximin). 2021 DME data shows 136 claims. Open Payments data shows 45 records totaling $37,272. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $57,175 and ending at $46,106. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $2,606,369 to $460,766. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	252	682	$57,175
2016	265	788	$66,457
2017	180	325	$23,723
2018	N/R	N/R	N/R
2019	59	98	$7,828
2020	210	562	$44,273
2021	56	127	$12,542
2022	124	331	$31,674
2023	168	447	$42,486
2024	220	496	$46,106

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	136	903	$2,606,369
2016	151	1,157	$1,073,382
2017	121	753	$348,202
2018	18	33	$5,624
2019	59	116	$28,229
2020	206	711	$368,320
2021	102	241	$159,984
2022	112	402	$344,255
2023	134	430	$452,819
2024	139	513	$460,766

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	76	$8,455
2016	57	375	$27,959
2017	73	364	$19,936
2018	N/R	N/R	N/R
2019	N/R	26	$395
2020	167	863	$97,610
2021	44	136	$2,834
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	51	54	$134
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	61	61	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	71	118	$98
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	46	84	$95
91200	Measurement of liver stiffness	72	75	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xifaxan	Rifaximin	19	570	$70,932
Linzess	Linaclotide	11	390	$7,055
Sutab	Sod Sulf/Pot Chloride/Mag Sulf	20	39	$3,234
Ursodiol	Ursodiol	30	1,320	$2,384
Pantoprazole Sodium	Pantoprazole Sodium	199	11,931	$2,295

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$37,272	Madrigal Pharmaceuticals
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adnan Muhammad, M.D.?

Tedicare shows public-source Medicare data for Adnan Muhammad, M.D. (NPI 1942242938), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adnan Muhammad, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adnan Muhammad, M.D.?

Adnan Muhammad, M.D. is linked to FLORIDA HOSPITAL PHYSICIAN GROUP INC (billing NPI 1174955256) in the available physician profile data.

Does Adnan Muhammad, M.D. have Open Payments data?

Adnan Muhammad, M.D. has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.